Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

Summary

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment (MCI).

Timeline

Start

2003-01

Primary completion

—

Completion

2004-05

Outcome

Outcome not reported

Stopped: “The Principal Investigator left the clinic and there was no one who could take over this study.”

Drugs

Indications